Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 3 |
2019 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
bioRxiv [Preprint]. 2024 Mar 29:2024.02.22.581560. doi: 10.1101/2024.02.22.581560.
bioRxiv. 2024.
PMID: 38464251
Free PMC article.
Preprint.
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.
Rasool RU, Natesan R, Deng Q, Aras S, Lal P, Sander Effron S, Mitchell-Velasquez E, Posimo JM, Carskadon S, Baca SC, Pomerantz MM, Siddiqui J, Schwartz LE, Lee DJ, Palanisamy N, Narla G, Den RB, Freedman ML, Brady DC, Asangani IA.
Rasool RU, et al.
Cancer Discov. 2019 Nov;9(11):1538-1555. doi: 10.1158/2159-8290.CD-19-0189. Epub 2019 Aug 29.
Cancer Discov. 2019.
PMID: 31466944
Free PMC article.
Item in Clipboard
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
Gollavilli PN, Pawar A, Wilder-Romans K, Natesan R, Engelke CG, Dommeti VL, Krishnamurthy PM, Nallasivam A, Apel IJ, Xu T, Qin ZS, Feng FY, Asangani IA.
Gollavilli PN, et al.
Cancer Res. 2018 Aug 15;78(16):4760-4773. doi: 10.1158/0008-5472.CAN-18-0484. Epub 2018 Jun 13.
Cancer Res. 2018.
PMID: 29898995
Item in Clipboard
Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer.
Pawar A, Gollavilli PN, Wang S, Asangani IA.
Pawar A, et al.
Cell Rep. 2018 Feb 27;22(9):2236-2245. doi: 10.1016/j.celrep.2018.02.011.
Cell Rep. 2018.
PMID: 29490263
Free article.
Item in Clipboard
The depalmitoylase APT1 directs the asymmetric partitioning of Notch and Wnt signaling during cell division.
Stypulkowski E, Asangani IA, Witze ES.
Stypulkowski E, et al.
Sci Signal. 2018 Jan 2;11(511):eaam8705. doi: 10.1126/scisignal.aam8705.
Sci Signal. 2018.
PMID: 29295957
Free PMC article.
Item in Clipboard
BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer.
Asangani IA, Wilder-Romans K, Dommeti VL, Krishnamurthy PM, Apel IJ, Escara-Wilke J, Plymate SR, Navone NM, Wang S, Feng FY, Chinnaiyan AM.
Asangani IA, et al.
Mol Cancer Res. 2016 Apr;14(4):324-31. doi: 10.1158/1541-7786.MCR-15-0472. Epub 2016 Jan 20.
Mol Cancer Res. 2016.
PMID: 26792867
Free PMC article.
Item in Clipboard
Cite
Cite